Bradmer Pharmaceuticals Inc. Announces Grant of Options to Directors and Officers
2011年7月22日 - 5:05AM
Marketwired
Bradmer Pharmaceuticals Inc. (TSX VENTURE: BMR.H) announced today
that it has granted, subject to regulatory approval, options to
directors and officers of the company exercisable to acquire an
aggregate of 1,500,000 common shares, at a price of $0.10 per
share, expiring July 21, 2021.
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION PROVIDER (AS
THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE)
ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS
RELEASE.
Contacts: Bradmer Pharmaceuticals Inc. Paul Van Damme
416.987.6113 pvandamme@bradmerpharma.com
Bradmer Pharmaceuticals (TSXV:BMR.H)
過去 株価チャート
から 5 2024 まで 6 2024
Bradmer Pharmaceuticals (TSXV:BMR.H)
過去 株価チャート
から 6 2023 まで 6 2024
Real-Time news about Bradmer Pharmaceuticals (トロントベンチャー取引所): 0 recent articles
その他のBradmer Pharmaceuticals Inc.ニュース記事